GENF vs. OBD, SNG, IMM, BVX, FAB, APTA, CIZ, HEMO, EVG, and MTFB
Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include Oxford BioDynamics (OBD), Synairgen (SNG), ImmuPharma (IMM), BiVictriX Therapeutics (BVX), Fusion Antibodies (FAB), Aptamer Group (APTA), Cizzle Biotechnology (CIZ), Hemogenyx Pharmaceuticals (HEMO), Evgen Pharma (EVG), and Motif Bio (MTFB). These companies are all part of the "biotechnology" industry.
Genflow Biosciences vs. Its Competitors
Oxford BioDynamics (LON:OBD) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.
44.3% of Oxford BioDynamics shares are held by institutional investors. Comparatively, 9.2% of Genflow Biosciences shares are held by institutional investors. 16.8% of Oxford BioDynamics shares are held by insiders. Comparatively, 64.2% of Genflow Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Oxford BioDynamics has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Genflow Biosciences has a beta of 2.37, meaning that its stock price is 137% more volatile than the S&P 500.
Genflow Biosciences has a net margin of 778.46% compared to Oxford BioDynamics' net margin of -1,800.32%. Genflow Biosciences' return on equity of -208.12% beat Oxford BioDynamics' return on equity.
Genflow Biosciences has lower revenue, but higher earnings than Oxford BioDynamics. Genflow Biosciences is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Oxford BioDynamics' average media sentiment score of 0.00 equaled Genflow Biosciences'average media sentiment score.
Summary
Genflow Biosciences beats Oxford BioDynamics on 6 of the 11 factors compared between the two stocks.
Get Genflow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genflow Biosciences Competitors List
Related Companies and Tools
This page (LON:GENF) was last updated on 8/2/2025 by MarketBeat.com Staff
